Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial(†)

INTRODUCTION: To assess the efficacy of an abbreviated Stanford V regimen in patients with early-stage Hodgkin lymphoma (HL). PATIENTS AND METHODS: Patients with untreated nonbulky stage I–IIA supradiaphragmatic HL were eligible for the G4 study. Stanford V chemotherapy was administered for 8 weeks...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Advani, R. H., Hoppe, R. T., Baer, D., Mason, J., Warnke, R., Allen, J., Daadi, S., Rosenberg, S. A., Horning, S. J.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2013
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3603439/
https://ncbi.nlm.nih.gov/pubmed/23136225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mds542
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires